What Is an Axumin PET Scan in Prostate Cancer?
An Axumin PET scan is an advanced test used to find prostate cancer that has come back after treatment. It uses a tracer called Fluciclovine (18F), which prostate cancer cells absorb more than normal cells. After the tracer is injected, a PET scanner takes pictures that show where cancer may be growing. This test can detect cancer in the prostate bed, lymph nodes, bones, or other organs. It is helpful when PSA levels rise, but other scans look normal. The scan is quick, safe, and gives doctors accurate information to guide treatment.
How the Axumin PET Scan Works?
An Axumin PET scan uses a very small amount of a radioactive tracer, Fluciclovine (18F). The Fluciclovine (18F) is a synthetic amino acid analog. The cells require proteins for their growth, and proteins are composed of amino acids. Since prostate cancer cells grow faster, they take up more tracer. After the injection, the tracer spreads in the bloodstream and collects inside cancer cells.
A PET scanner detects the tracer and displays bright spots where cancer may be present.
The whole process is simple:
-
The patient gets the injection.
-
They wait a few minutes for the tracer to spread.
-
The scan is taken.
-
Doctors review the images.
The radiation level is low, and the tracer is naturally eliminated from the body over time. It does not cause pain or long-term side effects. The clear pictures allow doctors to locate even small areas of cancer.
Axumin PET vs. PSMA PET: What’s the Difference?
Both Axumin PET and PSMA PET are modern tests that help find prostate cancer. But they work differently.
PSMA PET scans look for a protein called PSMA, which is found on prostate cancer cells. These scans are very sensitive. But PSMA levels can be low in some patients, especially after hormone therapy or specific treatments. In such cases, PSMA PET may not clearly show cancer.
This is where Axumin PET becomes useful. It does not look for PSMA. Instead, it uses a tracer that cancer cells absorb because they grow fast and need more amino acids. This means Axumin PET can detect cancer even when PSMA PET cannot.
Key comparisons:
-
Axumin PET uses Fluciclovine (18F), while PSMA PET uses PSMA-binding tracers.
-
Axumin PET is particularly suitable for cases where the PSA level is rising, but the PSMA PET scan is negative or shows low uptake.
-
PSMA PET is more sensitive overall, but Axumin is more effective for certain patient groups.
-
Axumin PET was approved by the FDA earlier and is still widely used.
Both are valuable tools. Doctors choose the scan that best matches the patient’s case.
How Axumin PET Helps in Real Clinical Practice?
Axumin PET scans are helpful in prostate cancer management as physicians utilize these scans to determine where the prostate cancer has recurred and the extent of its spread. This helps them develop an appropriate and personalized treatment plan.
Here's how Axumin PET is used:
1. Early detection of recurrence
When PSA levels rise following surgery or radiation, Axumin PET can pinpoint precisely where the cancer is growing. Sometimes it is confined to only one small lymph node or a single area in the prostate bed. Identifying it early provides additional treatment options.
2. Checking the prostate bed
Many patients have recurrence in the area of removal of the prostate. Axumin PET can detect tiny spots of cancer that routine CT or MRI may miss.
3. Cancer in lymph nodes
Cancer is clearly visible in the scan of the pelvic lymph nodes or lymph nodes farther away. Such information helps doctors determine whether radiation or systemic therapy is necessary.
4. Detecting cancer in bones
Axumin PET can show prostate cancer that spreads to bones earlier than traditional bone scans.
5. Guiding treatment choices
Depending on the scan results, the doctor may recommend:
-
Radiation to the prostate bed.
-
Radiation to lymph nodes.
-
Surgery for isolated lymph nodes.
-
Medicines that treat cancer throughout the body.
6. Monitoring high-risk patients
Patients with aggressive prostate cancer benefit from more frequent imaging. Axumin PET provides accurate updates, allowing the treatment plan to be adjusted quickly.
7. Helping with radiation planning
If cancer is identified in specific areas, radiation can be administered exactly where required. This minimizes damage to healthy tissue and enhances the possibility of success.
Why Axumin PET Is Still Important Today?
Even though PSMA PET has become very popular, Axumin PET continues to be important because:
-
Some tumors do not strongly take up PSMA.
-
Some treatments lower PSMA protein levels.
-
Axumin PET works even when PSMA PET is unclear.
-
It performs well at low to moderate PSA levels.
-
It is FDA-approved specifically for recurrent prostate cancer.
Both tools are important, and many centers use both depending on the situation.
Conclusion
The Axumin PET scan helps doctors find prostate cancer early when it returns. It shows clear pictures of where the tumor is growing in the body. This allows doctors to choose the proper treatment quickly. For patients who do not respond well to PSMA scans, Axumin PET offers another strong option.
Key Takeaways
-
Axumin PET finds prostate cancer that returns after treatment.
-
It uses a tracer that cancer cells absorb faster than normal cells.
-
It is helpful when PSMA PET scans do not show clear results.
-
It guides treatment choices like radiation, surgery, and hormone therapy.
Talk to our doctor to know which scan is best for your situation.
